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V ARIETY of new immunosuppressive drugs with 
distinct and diverse modes of action are currently 
e valuated for their potential to control allograft and 
~;"K·nnllTrn·tt rejection. FK 506 is a macrolide lactone that. 
. like cyclosporine A (CyA). inhibits selectively very early 
events in CD4+ T-Iymphocyte activation and proliferation. 
In contrast. bredinin (BR; mizoribine). mycophenolic acid 
(MPA. the active moiety of RS61443), and brequinar 
sodium (BQR) inhibit later events in the cell cycle by 
interfering with purine (BR and MPA) or pyrimidine 
(BQR) biosynthesis. These antiproliferative drugs (BR, 
MPA, and BQR) are candidates to replace azathioprine in 
combination therapy with CyA or FK 506 and steroids. 
Because there is little published information concerning 
the influence, if any, of BR. MPA, and BQR on production 
of Ivmphokine message, we have examined mRNA tran-
scription for the immunoregulatory cytokines IL-2 and 
IL-IO in activated murine spleen cells. 
MATERIAlS AND METHODS 
Immunosuppressive Agents 
FK 506 (Fujisawa Pharmaceutical Co. Osaka, Japan) and MPA 
(Sigma Chemical Co, St Louis. Mo) were dissolved in absolute 
ethanol. DR (Asahi Chemical Co, Ltd, Tokyo, Japan). and DQR 
(Dupont Merck Pharmaceutical Co, Wilmington, Del) were dis-
solved in watA:c before further dilution in cell culture medium. 
Mouse T-Cell Activation and RNA Isolation 
Spleens WCR removed aseptically from male C57BLlO mice (8 to 
12 weeks of age) and nucleated cell suspensions prepared and 
washed after .f"ed cell lysis in Tris-bulfered NH.Cl, pH 7.2. The 
spleen cells were resuspended finally in RPMI-l640 (Gibco, Grand 
Island. NY) with 10% (vol/vol) fetal bovine serum (Gibco). They 
were stimutated with concanavalin A (Con A) (5I'81mL; Sigma) at 
a final cell cQncentration of 2.5 x l()6fmL in tissue culture tubes 
(Falcon, Becton Dickinson, Oxnard, CaIiO, for 24 hours in 5% 
CO2 in air at 37"C. FK 506, MPA, BR, or BQR were added at the 
beginninc of the culture. Twenty-four hours later, cells were 
harvested and washed twice with RPMI-l640 before total RNA 
was isolated. 
Cell Proliferation 
Cultures of Con A-stimulated mouse spleen cells were established 
as described above. 3HTdR was added at 48 hours and cells 
harvested using a multiple cell harvester at 72 hours. DNA 
synthesis was expressed as counts per minute and results as 
percent inhibition relative to untreated Con A-stimulated con-
trols. 
Detection of Cytokine Gene Expression by Polymerase 
Chain Reaction (peR) 
Cells were harvested at 24 hours after Con A stimulation and total 
RNA extracted by the guanidinium-isotbiocyanate method 
(RNAzol. Cinna Biotecx, Friendswoods. Tex). A l-~ RNA 
sample was reverse-transcribed into cDNA using oligo-dT primer 
and MML V reverse transcriptase (Gibco BRL). This template 
eDNA was used for 30 or 40 cycles of PCR amplification using 
specific IL-2 and IL-IO oligonucleotide primers synthesized at tbe 
University of Pittsburgh DNA syntbesis facility. The PCR ampli-
fication was conducted using Taq polymerase (Perkin-Elmer, 
Norwalk. Conn) and a model 480 DNA Thermal Cycler (Perkin-
Elmer). The products of amplification. along with molecular 
weight markers for sizing, were separated on 2% agarose gels 
stained witb etbidium bromide, and photographed in ultraviolet 
light. Semiquantitative analysis was achieved by comparing visi-
bility of bands for seriailO-fold dilutions of input template DNA. 
J3-Actin primers were used in a separate PCR reaction to control 
for amount of template eDNA. 
RESULTS 
Proliferation 
Figure 1 shows the inhibitory effects of the various drugs 
on cell proliferation. Each drug, when added with the 
stimulus at the initiation of culture, showed a dose-
response curve with a maximum effect of >90% inhibition 
of proliferation. The 50% inhibitory concentration ElC~oF 
for FK 506 was approximately 0.2 ng/mL. The ICso for the 
other drugs was considerably higher: 30 ng/mL for BQR, 
35 ng/mL for MPA, and 250 ng/mL for BR. The drug 
concentrations chosen for the gene expression experi-
ments were FK 506, I ng/mL; MPA, 500 ng/mL; BR, 1000 
ng/Il)L; and BQR, 5000 ng/mL. At these concentrations, 
inhibition of DNA synthesis was >85% for each drug. 
Cytokine Gene Expression 
The reverse transcription PCR was performed using a 
standardized input amount of total RNA (l p.g). which was 
then reverse-transcribed into cDNA. In Fig 2 it can be seen 
that FK 506 strongly inhibited IL-2 production. However, 
MPA- and BR-treated cells showed the same level ofIL-2 
message as Con A-stimulated cells with no drug. As for 
IL-IO, there was a high basal level expressed in cells alone. 
With Con A stimulation, this level increased. With FK 506, 
MPA, or BR, the IL-lO message was still present. at 
greater than basal levels. Recently, IL-1O has been shown 
to be present in other cell types (macrophages, B cells, and 
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Fig 1. Con A-stimulated mouse 
spleen cells were cultured with 
immunosuppressive drugs at the 
concentrations indicated. Drugs 
were added at the same time as 
the stimulus at the initiation of 
culture. Percent inhibition was 
calculated from the cpm value of 
3HTdR incorporation compared 
with Can A-stimulated cells in 
media alone. 
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mast cells). and further experiments may be needed to 
confirm the cell of origin. It is clear that IL-2 mRNA was 
decreased by FK 506, but not IL-lO message. MPA and 
BR showed little effect on either of the cytokines studied. 
Figure 2 also shows the results for similar experiments 
using BQR. BQR did not selectively inhibit cytokine gene 
expression for IL-2 or IL-lO. We observed a more general 
effect of BQR in reducing all mRNA levels in the cell. 
including constitutive genes t3-actin and GAPDH (results 
not shown). This is probably due to its effect on pyrimidine 
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Fig 2. Effects of FK 506 (Fl<). MPA, BR. and BaR on expression 
of mRNA for IL-2 and IL-10. eDNA was amplified by PCR. IL-2: serial 
cDNA dilutions of 5.0.5, and 0.05 ng (A) or 5 and 0.5 ng (e). IL-10: 
serial cDNA dilutions of SO, 5, and 0.5 ng (8) or 5 and 0.5 ng (0). 
biosynthesis pathways, and inhibition of uridine and cyti-
dine production. 
DISCUSSION 
We have shown that, for several different immunosuppres-
sive drugs at concentrations that markedly inhibit cell 
proliferation, cytokine gene expression is selectively inhib-
ited only by FK 506, and not by MP A, BR. or BQR. This 
is not surprising, because FK 506 has been shown to act at 
an early stage to inhibit cytokine (such as IL-2) produc-
tion. 1 whereas MPA, BR. and BQR act at a step further 
along in the pathway from cell activation to proliferation. 
Our findings for BR are in agreement with those of Turka 
et al,2 who showed that BR failed to inhibit early events in 
T-cell activation, including expression ofmRNA for IL-2. 
It was also noted that although FK 506 markedly reduced 
IL-2, IL-IO expression was spared. A differential effect of 
FK 506 on IL-4 and IL-lO gene expression has been 
published previously with regard to a mouse T H2 cellline,3 
and may be linked to the immunosuppressive effect of the 
drug, because IL-lO has immunosuppressive properties.4 
In conclusion. it is important to look at the effects of new 
immunosuppressive drugs at the molecular level, because 
these agents have the potential to be used in combination 
to act at various points in the cell activation/proliferation 
pathway. FK 506 acts on early events to block cytokine 
production, whereas MPA, BR, and BQR act on later 
events that prevent cell proliferation . 
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